youtube_live
Q2 2027 earnings • released • EPS beat +4.44% • Revenue beat +3.72%
See resultschevron_right
GLAND:NSE
Gland Pharma Ltd
₹3,169.60
arrow_upward
+0.78%(+24.40) 1D
Nov 6, 3:30:02 PM GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GLAND...
Open
₹3,150.00
High
₹3,183.40
Low
₹3,133.20
Mkt. cap
523.02B
Avg. vol.
392.58K
Volume
351.95K
Dividend
0.63%
Quarterly dividend
₹5.00
Ex-dividend date
Aug 11, 2026
P/E ratio
46.35
52-wk high
₹3,208.60
52-wk low
₹1,573.60
EPS
₹68.39
No. of employees
4K
Open
₹3,150.00
High
₹3,183.40
Low
₹3,133.20
Mkt. cap
523.02B
Avg. vol.
392.58K
Volume
351.95K
Dividend
0.63%
Quarterly dividend
₹5.00
Ex-dividend date
Aug 11, 2026
P/E ratio
46.35
52-wk high
₹3,208.60
52-wk low
₹1,573.60
EPS
₹68.39
No. of employees
4K
News stories
From web sources and news partners
Yahoo Finance
·
12 hours ago
Gland Pharma Ltd (NSE:GLAND) (Q2 2027) Earnings Call Highlights: Revenue Jumps 23% as CDMO and ...
TradingView
·
1 day ago
GLAND: Q2 revenue rose 23% and PAT 58%, led by US and CDMO growth
About Gland Pharma Ltd
CEOShyamakant Giri
Employees4.33K
Founded1978
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteglandpharma.com